Concepedia

D.H. Lee

DL

Statistics

Publications

6

Citations

495

H-Index

6

Active since

2007

Affiliations

Asan Medical Center(Current)

Yonsei University

Rambam Health Care Campus

Merck & Co., Inc., Rahway, NJ, USA (United States)

Banner MD Anderson Cancer Center

D.H. Lee is an author at Asan Medical Center specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

2007–2021

6

Publications

6

First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer☆

Jiaxin Niu, Corinne Maurice‐Dror, D.H. Lee et al. · Annals of Oncology · 2021 · 273 citations · Full text

Placement of Covered Stents for Carotid Blowout in Patients with Head and Neck Cancer: Follow-up Results after Rescue Treatments

Hae Wook Pyun, D.H. Lee, Hyeon Mi Yoo et al. · American Journal of Neuroradiology · 2007 · 67 citations · Full text

Belotecan, new camptothecin analogue, is active in patients with small-cell lung cancer: results of a multicenter early phase II study

D.H. Lee, S.-W. Kim, Cheolwon Suh et al. · Annals of Oncology · 2007 · 58 citations · Full text

, , +9

Effect of active smoking on asthma symptoms, pulmonary function, and BHR in adolescents

Sun Mi Yoo, H‐B. Kim, S‐Y. Lee et al. · Pediatric Pulmonology · 2009 · 46 citations

1400P Vibostolimab, an anti-TIGIT antibody, as monotherapy and in combination with pembrolizumab in anti-PD-1/PD-L1-refractory NSCLC

M-J. Ahn, Jiaxin Niu, Dongwook Kim et al. · Annals of Oncology · 2020 · 29 citations

, , +7

1–5 of 6